Tech Company Financing Transactions
InCode BioPharmaceutics Funding Round
On 12/31/2006, InCode BioPharmaceutics announced $1.1 million in investment from Avalon Ventures.
Transaction Overview
Company Name
Announced On
12/31/2006
Transaction Type
Venture Equity
Amount
$1,149,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
P.O. Box 7118
Thousand Oaks, CA 91359
USA
Thousand Oaks, CA 91359
USA
Phone
Website
Email Address
Overview
The company develops therapeutic compounds to treat autoimmune disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Stark
Browse more venture capital transactions:
Prev: 12/31/2006: Tippit venture capital transaction
Next: 12/31/2006: Turn venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs